BEACTICA

Beactica Therapeutics is a precision oncology company developing novel, life-saving small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need... Today, Beactica Therapeutics is setting the pace in the cancer drug development landscape, with a strong focus on leveraging synthetic lethality to develop novel therapeutics for genetically defined cancers. This position at the forefront of the field, is rooted in Beactica's unique heritage spanning decades of research and industrial development.

Also known as: Beactica Therapeutics

Registration numbers: 556708-2853 (W)

VAT numbers: SE556708285301

Primary location: Uppsala Sweden